Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 4
4 · CARGO Therapeutics, Inc. · Filed Nov 16, 2023
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2023-11-14+737,000→ 737,000 total - Conversion
Series A-1 Preferred Stock
2023-11-14−10,000,000→ 0 total→ Common Stock (737,000 underlying)
Footnotes (1)
- [F1]Upon the closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 13.5685-for-one basis. The Series A-1 Preferred Stock had no expiration date.